Phil Aylward - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Current Cardiology Reports|July 1, 2005

Facilitated percutaneous coronary intervention: is this strategy ready for implementation?Derek P Chew, Phil Aylward, Harvey D White

Journal of the American College of Cardiology|September 10, 2016

Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 AnalysisJan Steffel, Robert P Giugliano, Eugene Braunwald, et al.

Lancet (London, England)|February 21, 2004

International differences in evolution of early discharge after acute myocardial infarctionPadma Kaul, L Kristin Newby, Yuling Fu, et al.

JAMA|July 9, 2004

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trialJames J Ferguson, Robert M Califf, Elliott M Antman, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Current Cardiology Reports|July 1, 2005

Facilitated percutaneous coronary intervention: is this strategy ready for implementation?Derek P Chew, Phil Aylward, Harvey D White

Journal of the American College of Cardiology|September 10, 2016

Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 AnalysisJan Steffel, Robert P Giugliano, Eugene Braunwald, et al.

Lancet (London, England)|February 21, 2004

International differences in evolution of early discharge after acute myocardial infarctionPadma Kaul, L Kristin Newby, Yuling Fu, et al.

JAMA|July 9, 2004

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trialJames J Ferguson, Robert M Califf, Elliott M Antman, et al.

Pageof 1